Loading company details...
Beta
Latest Form 4 (Jul 20, 2026): Kevin Finney (Director): Grant/Award of 39,400 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 20, 2026 | Kevin Finney | Grant/Award | 39,400 | n/a |
| Jul 18, 2026 | James B. Breitmeyer | Grant/Award | 8,315 | n/a |
| Jul 18, 2026 | Elaine J. Heron | Grant/Award | 39,400 | n/a |
| Jul 18, 2026 | W. Mark Watson | Grant/Award | 39,400 | n/a |
| Jul 18, 2026 | David E. Wheadon | Grant/Award | 39,400 | n/a |
| May 26, 2026 | W. Mark Watson | Purchase | 10,000 | $6.5K |
| May 21, 2026 | Jeroen Nicolaas Grasman, Chief Financial Officer | Tax Withholding | 31,395 | $19.2K |
| May 2, 2026 | James B. Breitmeyer | Grant/Award | 78,800 | n/a |
| Mar 31, 2026 | Sean Tucker, SVP, Chief Scientific Officer | Tax Withholding | 3,924 | $2.6K |
| Mar 31, 2026 | James F. Cummings, Chief Medical Officer | Tax Withholding | 3,292 | $2.1K |